Trial
Just got the news that I start the clinica trial at MGH 4/6/17 with Varliumab and Nivoulmab. Every other Thursday. Looking forward to starting this journey.
Comments
-
Great news
That's great Ed. Look's like we're on the same schedule, albiet I'm not getting Varliumab.
0 -
Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
0 -
Mass General Hospital.pamstayner said:Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
Mass General Hospital.
0 -
Trialpamstayner said:Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
I think this is the one. Mine has spread to my lungs.
https://www.clinicaltrials.gov/ct2/show/NCT02659059?term=NCT02659059&rank=1
0 -
TrialEd Brabant said:Trial
I think this is the one. Mine has spread to my lungs.
https://www.clinicaltrials.gov/ct2/show/NCT02659059?term=NCT02659059&rank=1
Just requested the number from Mass General. Bit of a hiccup. Biopsy tissue sample is too small. Waiting for a plan of action. Might be able to use the tissue from 2011 when I had my right kidney removed. Hope to hear by Thursday.
0 -
Trial InfoEd Brabant said:Trial
Just requested the number from Mass General. Bit of a hiccup. Biopsy tissue sample is too small. Waiting for a plan of action. Might be able to use the tissue from 2011 when I had my right kidney removed. Hope to hear by Thursday.
16-217:
Protocol Title: A Phase I/II, Dose-Escalation and Cohort Expansion Study of the
Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered
in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
(cdx1127-02)
Sponsor Protocol Number: CDX1127-02
0 -
Trial Infopamstayner said:Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
16-217:
Protocol Title: A Phase I/II, Dose-Escalation and Cohort Expansion Study of the
Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered
in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
(cdx1127-02)
Sponsor Protocol Number: CDX1127-02
0 -
Trial #pamstayner said:Do you know the trial number?
I don't know what MGH stands for. When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it.
Could you give me more info on this trial?
Here is the trial.
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards